Assessing patent owners’ fightback against hedge fund IPRs
With the PTAB soon to issue institution decisions on the controversial IPR petitions from the Coalition for Affordable Drugs and Ferro Ferrum Capital, patent owners have hit back through sanctions and additional discovery, and a complaint for attempted extortion
The Patent Trial and Appeal Board (PTAB) will in August start issuing its verdicts on whether it will institute proceedings on some of the most controversial inter partes review (IPR) petitions filed.
On February 10, the Coalition for Affordable Drugs...
Please log in
to read the rest of this article. New to Managing Intellectual Property?
Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.
Please make sure you log in to read the rest of the article.
Join us nowGain FREE access to up to five free articles when you register now.